ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

PRPO Precipio Inc

5.7499
-0.1501 (-2.54%)
시간외 거래
최종 업데이트: 05:00:06
15분 지연
기업명 주식 심볼 시장 주식 타입
Precipio Inc PRPO 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.1501 -2.54% 5.7499 05:00:06
개장가 저가 고가 종가 전일 종가
5.91 5.61 6.079 5.7499 5.90
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
26/03/202406:00GLOBEPrecipio Announces Year end 2023 Shareholder Update Call
14/02/202400:00GLOBEPrecipio to Report $15.2M for FY-2023 (unaudited) Revenues,..
07/02/202400:00GLOBEPrecipio and Cardinal Health Sign Distribution Agreement for..
24/01/202400:00GLOBEPrecipio’s Q4-2023 Cash Burn From Operations (unaudited)..
20/01/202406:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
18/01/202400:30GLOBEPrecipio Signs Distribution Agreement For IV-Cell® and..
05/01/202406:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202406:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/01/202407:01EDGAR2Form 8-K - Current report
02/01/202423:00GLOBEPrecipio Announces Christina Valauri joins the Board of..
15/12/202307:00EDGAR2Form 8-K - Current report
15/12/202306:30GLOBEPrecipio Management Shares Thoughts on 2023, and Looks Ahead..
17/11/202307:15EDGAR2Form 8-K - Current report
17/11/202307:00GLOBEPrecipio Announces Q3-2023 Shareholder Update Call
14/11/202306:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/10/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/10/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/10/202305:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202322:00GLOBEPrecipio to Report $4.5M Q3-2023 Revenues, Double From..
07/10/202305:34EDGAR2Form 8-K - Current report
03/10/202323:00GLOBEPrecipio’s Q3 Cash Burn From Operations (unaudited) Declines..
28/09/202322:00GLOBEPrecipio Continues to Sign New HemeScreen™ Customers
26/09/202300:00GLOBEPrecipio Reduces Product Revenue Result Needed for Cash Flow..
22/09/202306:10EDGAR2Form 8-K - Current report
15/09/202305:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/09/202305:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/09/202305:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/09/202305:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/09/202305:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/09/202305:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/09/202322:30GLOBEPrecipio’s Pathology Division Exceeds Breakeven Revenues in..
15/08/202305:00EDGAR2Form 8-K - Current report
12/08/202305:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202306:00GLOBEPrecipio Announces Q2-2023 Shareholder Update Call
08/08/202322:00GLOBEPrecipio Launches Its Much-Anticipated Quantitative BCR-ABL..
03/08/202322:00GLOBEPrecipio’s Operational Efficiency Measures Continue To..
01/08/202322:00GLOBEPrecipio Unaudited Q2-2023 Revenues Show combined increase..
08/07/202305:30EDGAR2Form S-1 - General form for registration of securities under..
14/06/202322:49GLOBEPrecipio’s Omnia™ Methodology Enables Diagnosis of MDS With..
13/06/202322:00GLOBEPrecipio Enters into Collaboration with Prestigious New..
08/06/202321:30GLOBEPrecipio, Inc. Announces Pricing of $2 Million Registered..
07/06/202322:30GLOBEProjected cash burn reduced by $1.5 million annually from..
23/05/202300:00GLOBEPrecipio’s Lab Detects BCR-ABL1 Oncogene Co-Expression of..
18/05/202305:00GLOBEPrecipio Shares Growth Catalysts For HemeScreen
16/05/202305:00GLOBEPrecipio Announces Q1-2023 Shareholder Update Call
05/05/202302:00GLOBEPrecipio Adds Substantial Pathology Customer to its..
04/05/202323:00GLOBEPrecipio Signs Another HemeScreen™ Customer

최근 히스토리

Delayed Upgrade Clock